Literature DB >> 18949383

IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance.

Dung-Fang Lee1, Hsu-Ping Kuo, Chun-Te Chen, Yongkun Wei, Chao-Kai Chou, Jen-Yu Hung, Chia-Jui Yen, Mien-Chie Hung.   

Abstract

The proinflammatory cytokine TNFalpha is one of the factors that links obesity-derived chronic inflammation with insulin resistance. Activation of mTOR signaling pathway has been found to suppress insulin sensitivity through serine phosphorylation and the inhibition of IRS1 by mTOR and its downstream effector, S6K1. It remains elusive that whether the mTOR pathway has a role in TNFalpha-mediated insulin resistance. In the present study, we demonstrated that TNFalpha-IKKbeta-mediated inactivation of TSC1 resulted in increasing phosphorylation of IRS1 serine 307 and serine 636/639, impaired insulin-induced glucose uptake, tyrosine phosphorylation of IRS1, and the association between IRS1 and PI3K p85. Furthermore, a higher expression of pIKKbeta (S181), pTSC1(S511), and pS6(S240/244) was found in livers obtained from both C57BL/6J mice on a high-fat diet and B6.V-Lepob/J mice. Collectively, dysregulation of the TSC1/ TSC2/mTOR signaling pathway by IKKbeta is a common molecular switch for both cancer pathogenesis and diet- and obesity-induced insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949383      PMCID: PMC2586899          DOI: 10.3892/ijmm_00000065

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  24 in total

1.  The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).

Authors:  V Aguirre; T Uchida; L Yenush; R Davis; M F White
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Authors:  M Yuan; N Konstantopoulos; J Lee; L Hansen; Z W Li; M Karin; S E Shoelson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

3.  IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

Authors:  Mickey C-T Hu; Dung-Fang Lee; Weiya Xia; Leonard S Golfman; Fu Ou-Yang; Jer-Yen Yang; Yiyu Zou; Shilai Bao; Norihisa Hanada; Hitomi Saso; Ryuji Kobayashi; Mien-Chie Hung
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

Review 4.  Obesity, adipocytokines, and insulin resistance in breast cancer.

Authors:  D P Rose; D Komninou; G D Stephenson
Journal:  Obes Rev       Date:  2004-08       Impact factor: 9.213

5.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 6.  All roads lead to mTOR: integrating inflammation and tumor angiogenesis.

Authors:  Dung-Fang Lee; Mien-Chie Hung
Journal:  Cell Cycle       Date:  2007-09-20       Impact factor: 4.534

7.  Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

Authors:  Zhanguo Gao; Daniel Hwang; Fredly Bataille; Michael Lefevre; David York; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

8.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.

Authors:  Sung Hee Um; Francesca Frigerio; Mitsuhiro Watanabe; Frédéric Picard; Manel Joaquin; Melanie Sticker; Stefano Fumagalli; Peter R Allegrini; Sara C Kozma; Johan Auwerx; George Thomas
Journal:  Nature       Date:  2004-08-11       Impact factor: 49.962

9.  Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1.

Authors:  Klaus Moeschel; Alexander Beck; Cora Weigert; Reiner Lammers; Hubert Kalbacher; Wolfgang Voelter; Erwin D Schleicher; Hans-Ulrich Häring; Rainer Lehmann
Journal:  J Biol Chem       Date:  2004-04-05       Impact factor: 5.157

10.  The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.

Authors:  Laura S Harrington; Greg M Findlay; Alex Gray; Tatiana Tolkacheva; Simon Wigfield; Heike Rebholz; Jill Barnett; Nick R Leslie; Susan Cheng; Peter R Shepherd; Ivan Gout; C Peter Downes; Richard F Lamb
Journal:  J Cell Biol       Date:  2004-07-12       Impact factor: 10.539

View more
  27 in total

Review 1.  β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.

Authors:  Xiaotao Feng; Wenjian Wang; Jibo Liu; Yi Liu
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 3.  mTOR signaling at a glance.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  J Cell Sci       Date:  2009-10-15       Impact factor: 5.285

4.  Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer.

Authors:  Chun-Te Chen; Yi Du; Hirohito Yamaguchi; Jung-Mao Hsu; Hsu-Ping Kuo; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Mol Cancer Ther       Date:  2012-07-23       Impact factor: 6.261

Review 5.  Treatment strategies and clinical trial design in ADPKD.

Authors:  Vicente E Torres
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

6.  Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.

Authors:  Shi-Bing Yang; Hye Young Lee; David Matthew Young; An-Chi Tien; Ashley Rowson-Baldwin; Yu Yu Shu; Yuh Nung Jan; Lily Yeh Jan
Journal:  J Mol Med (Berl)       Date:  2011-11-22       Impact factor: 4.599

7.  Resistance exercise, but not endurance exercise, induces IKKβ phosphorylation in human skeletal muscle of training-accustomed individuals.

Authors:  Andreas Buch Møller; Mikkel Holm Vendelbo; Stine Klejs Rahbek; Berthil Forrest Clasen; Peter Schjerling; Kristian Vissing; Niels Jessen
Journal:  Pflugers Arch       Date:  2013-07-10       Impact factor: 3.657

8.  Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease.

Authors:  Kristen R Taylor; Robyn E Mills; Anne E Costanzo; Julie M Jameson
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

9.  Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.

Authors:  Prakash Radhakrishnan; Vashti C Bryant; Elizabeth C Blowers; Rajkumar N Rajule; Nagsen Gautam; Muhammad M Anwar; Ashley M Mohr; Paul M Grandgenett; Stephanie K Bunt; Jamie L Arnst; Subodh M Lele; Yazen Alnouti; Michael A Hollingsworth; Amarnath Natarajan
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

Review 10.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.

Authors:  K D Copps; M F White
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.